Frédéric Dreyer
About Frédéric Dreyer
Frédéric Dreyer is a Senior AI Research Scientist and Group Leader at Exscientia, where he leads a team focused on artificial intelligence applications in drug discovery. He has an extensive academic background in physics and machine learning, with experience at renowned institutions such as MIT, CERN, and the University of Oxford.
Work at Exscientia
Frédéric Dreyer currently serves as a Senior AI Research Scientist and Group Leader at Exscientia, a position he has held since 2023. In this role, he leads a team focused on the application of artificial intelligence in the development of small molecules and biologics. His work contributes to advancing the integration of AI technologies in pharmaceutical research and development.
Education and Expertise
Frédéric Dreyer has a comprehensive educational background in physics and related fields. He holds a Doctor of Philosophy (PhD) in Theoretical Physics from Sorbonne University, a Master of Science (MSc) in High Energy Physics from École Polytechnique, and a Master of Science (MSc) in Physics from ETH Zürich. Additionally, he has completed various programs, including a Data Science Starter Program at Ecole Polytechnique and a Certificate in Immunology and Pharmacology from HMX – Harvard Medical School.
Background
Frédéric Dreyer has extensive experience in both academic and industry settings. He has worked at prestigious institutions such as CERN, MIT, and the University of Oxford. His career includes roles as a PhD Student at CERN and Sorbonne University, a Postdoctoral Fellow at MIT, and a Royal Society University Research Fellow at the University of Oxford. His diverse experiences have shaped his interdisciplinary approach, combining physics, machine learning, and protein design.
Previous Positions
Before joining Exscientia, Frédéric Dreyer held several significant positions. He worked as a Machine Learning Engineer at Meta for five months in 2022, and as a Teaching Assistant at ETH Zurich in 2012. His tenure at the University of Oxford included a Royal Society University Research Fellowship from 2018 to 2023. He also completed a CERN Summer Student program in 2012 and a research internship at the Institut d'Astrophysique de Paris in 2013.
Research Focus
Frédéric Dreyer's research focus has evolved from theoretical physics to applied artificial intelligence in the pharmaceutical industry. His work emphasizes the integration of machine learning techniques in drug discovery and development, particularly in the design of small molecules and biologics. This transition highlights his commitment to leveraging scientific knowledge for practical applications in healthcare.